N-Isopropylnoradrenaline en es it fr

N-Isopropylnoradrenaline Brand names, N-Isopropylnoradrenaline Analogs

N-Isopropylnoradrenaline Brand Names Mixture

  • No information avaliable

N-Isopropylnoradrenaline Chemical_Formula


N-Isopropylnoradrenaline RX_link


N-Isopropylnoradrenaline fda sheet

N-Isopropylnoradrenaline FDA

N-Isopropylnoradrenaline msds (material safety sheet)

N-Isopropylnoradrenaline Synthesis Reference

No information avaliable

N-Isopropylnoradrenaline Molecular Weight

211.258 g/mol

N-Isopropylnoradrenaline Melting Point

170.5 oC

N-Isopropylnoradrenaline H2O Solubility

No information avaliable

N-Isopropylnoradrenaline State


N-Isopropylnoradrenaline LogP


N-Isopropylnoradrenaline Dosage Forms


N-Isopropylnoradrenaline Indication

For the treatment of mild or transient episodes of heart block that do not require electric shock or pacemaker therapy also used in management of asthma and chronic bronchitis

N-Isopropylnoradrenaline Pharmacology

Isoproterenol is a relatively selective beta2-adrenergic bronchodilator. Isoproterenol is indicated for the relief of bronchospasm associated with chronic obstructive pulmonary disease. The pharmacologic effects of beta adrenergic agonist drugs, including Isoproterenol, are at least in part attributable to stimulation through beta adrenergic receptors of intracellular adenyl cyclase, the enzyme which catalyzes the conversion of adenosine triphosphate (ATP) to cyclic- 3',5'- adenosine monophosphate (c-AMP). Increased c-AMP levels are associated with relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells.

N-Isopropylnoradrenaline Absorption

No information avaliable

N-Isopropylnoradrenaline side effects and Toxicity

No information avaliable

N-Isopropylnoradrenaline Patient Information

No information avaliable

N-Isopropylnoradrenaline Organisms Affected

Humans and other mammals